Group One Trading’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
Other funds holding BCYC
BBA
LFCM
Group One Trading's BCYC Position: Q3 2026 in Review
Group One Trading increased its Bicycle Therapeutics (BCYC) stake by 72% in Q3 2026, buying an estimated $5.66K and bringing the position to 3,338 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6184.
Group One Trading first reported a position in BCYC in Q4 2022 and has held it in 11 quarters since. The position peaked at $2.14M in Q2 2023. 90 funds tracked by Wall St. Rank hold BCYC as of Q3 2026.
- Group One Trading held 3,338 shares of Bicycle Therapeutics worth $12.3K as of Q3 2026.
- Group One Trading bought 1,400 Bicycle Therapeutics shares in Q3 2026, an estimated $5.66K.
- Bicycle Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #6184 holding.
- Group One Trading first reported a position in Bicycle Therapeutics in Q4 2022 and has held it in 11 quarters since.
- Group One Trading's Bicycle Therapeutics position peaked at $2.14M in Q2 2023.
- 90 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.